Home/Filings/4/0001628908-22-000029
4//SEC Filing

Tutewohl Steve 4

Accession 0001628908-22-000029

CIK 0001628908other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:15 PM ET

Size

12.6 KB

Accession

0001628908-22-000029

Insider Transaction Report

Form 4
Period: 2022-03-01
Tutewohl Steve
Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2022-03-01+20,000118,843 total
  • Tax Payment

    Class A Common Stock

    2022-03-01$27.40/sh4,005$109,737114,838 total
  • Exercise/Conversion

    Class A Common Stock

    2022-03-01$13.29/sh+5,388$71,607121,130 total
  • Sale

    Class A Common Stock

    2022-03-01$27.41/sh5,388$147,685114,838 total
  • Exercise/Conversion

    Class A Common Stock Option (right to buy)

    2022-03-015,3885,388 total
    Exercise: $13.29Exp: 2029-03-01Class A Common Stock (5,388 underlying)
Footnotes (7)
  • [F1]Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025.
  • [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
  • [F5]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $28.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The Class A Common Stock Options exercised vested on March 1, 2022.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001811845

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:15 PM ET
Size
12.6 KB